Anavex Life Sciences(DE:12X1)
€0.87-0.07 (-7.09%)
DE:12X1
Anavex Life Sciences financials statements
€0.87
At close:-0.07 (-7.09%)
Anavex Life Sciences (12X1) Income Statement
2 Followers
Anavex Life Sciences Income Statement
Last quarter (Q3 2026), Anavex Life Sciences's total revenue was $0.00. In Q3, Anavex Life Sciences's net income was $7.82M. See Anavex Life Sciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 51.41M | $ 52.88M | $ 55.76M | $ 50.99M | $ 42.00M | |
| Depreciation and Amortization | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| $ -46.38M | $ -43.00M | $ -46.54M | $ -47.62M | $ -37.64M | |
| $ -51.41M | $ -52.88M | $ -55.76M | $ -50.99M | $ -42.00M | |
| $ 5.03M | $ 9.88M | $ 8.26M | $ 3.37M | $ 4.36M | |
| $ -46.38M | $ -43.00M | $ -47.51M | $ -47.62M | $ -37.64M | |
| $ -46.38M | $ -43.00M | $ -47.51M | $ -47.98M | $ -37.91M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.54 | $ -0.52 | $ -0.60 | $ -0.62 | $ -0.54 |
| Diluted EPS | $ -0.54 | $ -0.52 | $ -0.60 | $ -0.62 | $ -0.54 |
| Weighted Average Shares Outstanding | 85.29M | 83.47M | 79.79M | 76.91M | 69.80M |
| Weighted Average Shares Outstanding (Diluted) | 85.29M | 83.47M | 79.79M | 76.91M | 69.80M |
Currency in USD
